Venus Medtech still seeking cure for governance problems
The transcatheter maker’s shares were suspended last November, and it must still meet several conditions from the Hong Kong Stock Exchange before trading can resume Key Takeways: Venus Medtech disclosed…
Recent Articles
RELATED ARTICLES
-
FAST NEWS: Venus Medtech’s loss narrows on surging overseas sales
2500.HK -
Lufax takes on more risk, makes Hong Kong acquisition, as its lending shrivels
6623.HK LU.US
-
Luzhou Bank’s profit growth looks sweet, but could mask souring loans
1983.HK
-
FAST NEWS: PW Medtech’s profit jumps on post-Covid rebound
1358.HK
-
Henderson Land gets $7.7 billion helping hand in drive to become new ‘King of Central’
0012.HK
- Facing anemic trading, Hong Kong considers staying open in foul weather
